Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Statistics

Total Valuation

PHIO has a market cap or net worth of $7.56 million. The enterprise value is -$3.15 million.

Market Cap	7.56M
Enterprise Value	-3.15M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

PHIO has 5.73 million shares outstanding. The number of shares has increased by 570.72% in one year.

Current Share Class	5.73M
Shares Outstanding	5.73M
Shares Change (YoY)	+570.72%
Shares Change (QoQ)	+14.05%
Owned by Insiders (%)	0.87%
Owned by Institutions (%)	11.35%
Float	5.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.78
P/TBV Ratio	0.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.90

Current Ratio	6.90
Quick Ratio	6.43
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -107.58% and return on invested capital (ROIC) is -70.68%.

Return on Equity (ROE)	-107.58%
Return on Assets (ROA)	-60.16%
Return on Invested Capital (ROIC)	-70.68%
Return on Capital Employed (ROCE)	-84.97%
Revenue Per Employee	n/a
Profits Per Employee	-$1.59M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.27% in the last 52 weeks. The beta is 0.89, so PHIO's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	-40.27%
50-Day Moving Average	2.07
200-Day Moving Average	2.00
Relative Strength Index (RSI)	23.03
Average Volume (20 Days)	8,653,026

Short Selling Information

The latest short interest is 232,245, so 4.06% of the outstanding shares have been sold short.

Short Interest	232,245
Short Previous Month	270,688
Short % of Shares Out	4.06%
Short % of Float	4.09%
Short Ratio (days to cover)	2.57

Income Statement

Revenue	n/a
Gross Profit	-985,000
Operating Income	-8.36M
Pretax Income	-7.95M
Net Income	-7.95M
EBITDA	-8.36M
EBIT	-8.36M
Earnings Per Share (EPS)	-$2.02

Balance Sheet

The company has $10.71 million in cash and n/a in debt, giving a net cash position of $10.71 million or $1.87 per share.

Cash & Cash Equivalents	10.71M
Total Debt	n/a
Net Cash	10.71M
Net Cash Per Share	$1.87
Equity (Book Value)	9.84M
Book Value Per Share	1.70
Working Capital	9.83M

Cash Flow

In the last 12 months, operating cash flow was -$7.27 million and capital expenditures -$13,000, giving a free cash flow of -$7.28 million.

Operating Cash Flow	-7.27M
Capital Expenditures	-13,000
Free Cash Flow	-7.28M
FCF Per Share	-$1.27

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PHIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-570.72%
Shareholder Yield	-570.72%
Earnings Yield	-105.21%
FCF Yield	-96.36%

Analyst Forecast

The average price target for PHIO is $10.67, which is 708.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.67
Price Target Difference	708.33%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 5, 2024. It was a reverse split with a ratio of 1:9.

Last Split Date	Jul 5, 2024
Split Type	Reverse
Split Ratio	1:9

Scores

Altman Z-Score	n/a
Piotroski F-Score	2